Vfend and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vfend (voriconazole) and Repaglinide (repaglinide). Common drug interactions include cholestasis among males.

The phase IV clinical study analyzes what interactions people have when they take Vfend and Repaglinide. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.



On Jul, 15, 2026

14 people who take Vfend and Repaglinide together, and have interactions are studied.

Vfend and Repaglinide drug interactions.

What are the common drug interactions of Vfend and Repaglinide, by gender? *:

female:

n/a

male:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Drug level increased
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Pneumonia
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)

What are the common drug interactions of Vfend and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Drug level increased
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  6. Pneumonia
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 85.71%
  2. Pain: 8 people, 57.14%
  3. Indigestion: 6 people, 42.86%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 28.57%
  5. Pneumonia Fungal: 4 people, 28.57%
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 28.57%
  7. Venoocclusive Disease (small veins in the liver are obstructed): 1 person, 7.14%
  8. Fever: 1 person, 7.14%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
  10. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vfend and Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vfend and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repaglinide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole and repaglinide (the active ingredients of Vfend and Repaglinide, respectively), and Vfend and Repaglinide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: